Tag: Cancer: Skin
Racial Differences Seen in Time to Treatment for Melanoma
Time from diagnosis to definitive surgery is twice as long on average for black versus white patients
Melanoma Risk From Biologic Therapy Remains Uncertain
Systematic literature review and meta-analysis reveal link to increased risk cannot be ruled out
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
Patients Underestimate Length of Mohs Surgery Scars
Physicians more accurately estimate scar length and can help set expectations
Large Decrease Seen in Melanoma Mortality From 2013 to 2016
Overall mortality decrease started in 2013 following introduction of 10 new treatments in 2011
Bereavement Tied to Higher Melanoma-Related Mortality
Authors suggest delayed diagnosis may result from lack of partner to notice skin changes
Dermatopathologists Favor Making Pathologic Reports Available
Making reports available to patients seen as good idea, but there is concern about patient worry, confusion
High Cutaneous Melanoma Burden Found Due to UV Radiation
Burden varies across states, with highest burden seen in Hawaii
Studies Explore Prevalence of Skin Cancer Among Sexual Minorities
Gay, bisexual men have increased odds of skin cancer; OR significantly higher for gender-nonconforming adults
Smartphone Apps Not Accurate Enough to Detect All Melanomas
SkinVision had sensitivity of 80 percent, but accuracy poor versus expert recommendation
